{Reference Type}: Journal Article
{Title}: [Interpretation of the UK screening and treatment of retinopathy of prematurity updated 2022 guidelines].
{Author}: Dong XY;Li JZ;Luo KR;Tang J;Mu DZ;
{Journal}: Zhongguo Dang Dai Er Ke Za Zhi
{Volume}: 26
{Issue}: 5
{Year}: 2024 May 15
暂无{DOI}: 10.7499/j.issn.1008-8830.2311073
{Abstract}: The UK screening and treatment of retinopathy of prematurity (ROP) updated 2022 guidelines were developed by a multidisciplinary guideline development group from the Royal College of Paediatrics and Child Health and the Royal College of Ophthalmologists, following the standards of the National Institute for Health and Care Excellence. They were published on the websites of the Royal College of Paediatrics and Child Health and the Royal College of Ophthalmologists in March 2022, and formally published in Early Human Development in March 2023. The guidelines provide evidence-based recommendations for the screening and treatment of ROP. The most significant change in the 2022 updated version compared to the previous guidelines is the lowering of the gestational age screening criterion to below 31 weeks. The treatment section covers treatment indications, timing, methods, and follow-up visits of ROP. This article interprets the guidelines and compares them with ROP guidelines/consensus in China, providing a reference for domestic peers.<BR>英国早产儿视网膜病变的筛查和治疗指南2022更新版由英国皇家儿科与儿童健康学院和皇家眼科学院的多学科指南制订小组按照英国国家卫生与临床优化研究所标准制订，于2022年3月发表在英国皇家儿科与儿童健康学院网站和皇家眼科学院网站，2023年3月在Early Human Development杂志正式发表。该指南对早产儿视网膜病变的筛查及治疗进行了循证推荐和建议。与更新前的指南相比，2022更新版最重要的变化是将胎龄筛查标准降至31周以下；治疗部分涵盖了早产儿视网膜病变的治疗适应证、时间、方法及随诊。该文对该指南进行解读并与国内早产儿视网膜病变指南/共识进行比较，为国内同行提供参考和借鉴。.